SYNDAX PHARMACEUTICALS

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02 7月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia

24 6月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Announces Publication of Revumenib Data from the BEAT AML Trial in the Journal of Clinical Oncology and Simultaneous Presentation at EHA 2025

12 6月 2025 09:02:01 条件 Nasdaq GlobeNewswire

Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025

12 6月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

05 6月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Announces Participation in June Investor Conferences

29 5月 2025 04:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

15 5月 2025 06:46:05 条件 NetDania Notify

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

14 5月 2025 09:02:02 条件 NetDania Notify

Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)

14 5月 2025 06:30:00 条件 Nasdaq GlobeNewswire

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

12 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Announces Participation in May Investor Conferences

08 5月 2025 04:00:01 条件 Nasdaq GlobeNewswire

Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood

07 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

05 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02 5月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

28 4月 2025 04:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

09 4月 2025 07:02:11 条件 NetDania Notify

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

07 4月 2025 06:45:35 条件 NetDania Notify

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04 4月 2025 13:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

04 4月 2025 06:55:56 条件 NetDania Notify

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

02 4月 2025 04:00:00 条件 Nasdaq GlobeNewswire